Free triiodothyronine, not thyroid stimulating hormone, should be focused on for risk stratification in acute decompensated heart failure.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Cardiology

• Publication date

  2015-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jjcc.2015.05.001PMID 26051635
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thyroid function on admission and outcome in patients hospitalized for acute decompensated heart failure.

  2015cited by this paper
• Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure).

  2014cited by this paper
• The effect of thyroid function on clinical outcome in patients with heart failure

  2014cited by this paper
• Thyroid and the heart.

  2014cited by this paper
• Thyroid function in heart failure and impact on mortality.

  2013cited by this paper
• Prognostic impact of subclinical thyroid dysfunction in heart failure.

  2013cited by this paper
• Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure.

  2010cited by this paper
• The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence

  2010cited by this paper
• Thyroid disease and the heart.

  2007cited by this paper
• Triiodothyronine levels for risk stratification of patients with chronic heart failure.

  2005cited by this paper
• Low-T3 Syndrome: A Strong Prognostic Predictor of Death in Patients With Heart Disease

  2003cited by this paper
• Thyroid hormone and the cardiovascular system.

  2001cited by this paper
• Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure.

  1998cited by this paper
• Thyroid hormone and the cardiovascular system.

  1997cited by this paper
• Altered thyroid hormone metabolism in advanced heart failure.

  1990cited by this paper
• Modulation of myocardial L-triiodothyronine receptors in normal, hypothyroid, and hyperthyroid rats.

  1986cited by this paper

• Cardioprotection by triiodothyronine following caloric restriction via long noncoding RNAs.

  2020cites this paper
• Correlation of GLUT1 and GLUT4 with prognosis of patients with hypothyroidism and cardiac insufficiency.

  2020cites this paper
• Modified Low-Dose Triiodo-L-thyronine Therapy Safely Improves Function Following Myocardial Ischemia-Reperfusion Injury

  2017cites this paper
• Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse Effects

  2016cites this paper